N-(1-(3-acrylamidobenzoyl)piperidin-4-yl)-4-(2,6-dichlorobenzamido)-1H-pyrazole-3-carboxamide 2,2,2-trifluoroacetate

ID: ALA4554744

PubChem CID: 155556153

Max Phase: Preclinical

Molecular Formula: C28H25Cl2F3N6O6

Molecular Weight: 555.42

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  C=CC(=O)Nc1cccc(C(=O)N2CCC(NC(=O)c3n[nH]cc3NC(=O)c3c(Cl)cccc3Cl)CC2)c1.O=C(O)C(F)(F)F

Standard InChI:  InChI=1S/C26H24Cl2N6O4.C2HF3O2/c1-2-21(35)30-17-6-3-5-15(13-17)26(38)34-11-9-16(10-12-34)31-25(37)23-20(14-29-33-23)32-24(36)22-18(27)7-4-8-19(22)28;3-2(4,5)1(6)7/h2-8,13-14,16H,1,9-12H2,(H,29,33)(H,30,35)(H,31,37)(H,32,36);(H,6,7)

Standard InChI Key:  XKBFRDLYPKVXJU-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 45 47  0  0  0  0  0  0  0  0999 V2000
   32.6885   -6.0046    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.3962   -5.5960    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.9808   -5.5960    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   32.6885   -6.8218    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   31.9787   -6.4091    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   34.1040   -6.0046    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   33.3962   -4.7789    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   26.9549   -5.2375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.7721   -5.2375    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.5463   -4.5297    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   26.5463   -5.9452    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.7300   -5.9424    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.3215   -6.6493    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.7302   -7.3580    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.5516   -7.3553    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.9564   -6.6479    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.3228   -5.2339    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   27.7736   -6.6444    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   29.4065   -5.2375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.1807   -4.5319    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.9979   -4.5297    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.2484   -3.7518    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   28.5859   -3.2732    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.9261   -3.7554    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.2237   -5.2375    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   28.9979   -5.9452    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   30.6323   -4.5297    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.4481   -4.5317    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.8566   -3.8281    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.4514   -3.1179    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.6333   -3.1160    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.2203   -3.8241    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.8627   -2.4118    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.6799   -2.4149    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.4568   -1.7025    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   33.0833   -3.1263    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.8997   -3.1297    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.3118   -2.4230    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.9015   -1.7114    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.0864   -1.7115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.3053   -3.8392    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.1225   -3.8426    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.5281   -4.5521    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.5341   -3.1367    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   36.3452   -4.5556    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  1  5  1  0
  2  6  1  0
  2  7  2  0
  8  9  1  0
  8 10  2  0
  8 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
 12 17  1  0
 16 18  1  0
  9 20  1  0
 21 19  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  1  0
 24 20  2  0
 19 25  1  0
 19 26  2  0
 25 27  1  0
 27 28  1  0
 27 32  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 30 33  1  0
 33 34  1  0
 33 35  2  0
 34 36  2  0
 36 37  1  0
 37 38  2  0
 38 39  1  0
 39 40  2  0
 40 34  1  0
 37 41  1  0
 41 42  1  0
 42 43  1  0
 42 44  2  0
 43 45  2  0
M  END

Associated Targets(Human)

CDK14 Tchem Cyclin-dependent kinase 14/Cyclin-Y (136 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK14 Tchem Serine/threonine-protein kinase PFTAIRE-1 (331 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 555.42Molecular Weight (Monoisotopic): 554.1236AlogP: 4.13#Rotatable Bonds: 7
Polar Surface Area: 136.29Molecular Species: NEUTRALHBA: 5HBD: 4
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 4#RO5 Violations (Lipinski): 1
CX Acidic pKa: 10.75CX Basic pKa: 0.01CX LogP: 3.79CX LogD: 3.79
Aromatic Rings: 3Heavy Atoms: 38QED Weighted: 0.33Np Likeness Score: -1.62

References

1. Ferguson FM, Doctor ZM, Ficarro SB, Marto JA, Kim ND, Sim T, Gray NS..  (2019)  Synthesis and structure activity relationships of a series of 4-amino-1H-pyrazoles as covalent inhibitors of CDK14.,  29  (15): [PMID:31175010] [10.1016/j.bmcl.2019.05.024]

Source